Home
About +
Our Story
Meet the Team
FAQs
Our Science +
Inhaled IFN-β
Clinical Trials
Publications
Factsheets
Investors +
Investor Overview
Investor News
Reports & Presentations
Major Shareholders & Advisers
Shareholder Information
TR-1/Options Press Release Archive
Careers
Contact
Home
About
Our Science
Investors
Careers
Contact
Back
Our Story
Meet the Team
FAQs
Back
Inhaled IFN-β
Clinical Trials
Publications
Factsheets
Back
Investor Overview
Investor News
Reports & Presentations
Major Shareholders & Advisers
Shareholder Information
TR-1/Options Press Release Archive
Investors
Investor News
Subscribe to news
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
Synairgen Corporate Update
26th February 2026
